MedTrace Logo

London Investigation Into diElectric Scanning of Lesions

NCT03302819 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 994

Last updated 2017-10-05

No results posted yet for this study

Summary

The MARIA breast imaging system is a novel CE-marked radio-frequency (RF) medical imaging device. The system employs an electromagnetic imaging technique that exploits the dielectric contrast between normal and cancerous tissues. The performance and imaging characteristics of MARIA are not yet well demonstrated. The investigators aim to evaluate some aspects of this potentially important new technology.

Conditions

Interventions

DIAGNOSTIC_TEST

MARIA scan

The patient will have an additional MARIA scan along with conventional imaging, pathology and surgical procedures.

Sponsors & Collaborators

  • Micrima, Ltd.

    collaborator INDUSTRY

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Steven Allen · Royal Marsden NHS Foundation Trust

  • Richard Sidebottom · Royal Marsden NHS Foundation Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-11-01
Completion
2018-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03302819 on ClinicalTrials.gov